Molecular Human Reproduction, Vol. 5, No. 4, 291-298,
April 1999
© 1999 European Society of Human Reproduction and Embryology
Steroidogenic enzyme expression in human corpora lutea in the presence and absence of exogenous human chorionic gonadotrophin (HCG)
1 MRC Reproductive Biology Unit, Centre for Reproductive Biology, 37 Chalmers Street, Edinburgh EH3 9EW, UK
In a human conception cycle, the expected decline in progesterone production by the corpus luteum during the late luteal phase is prevented by human chorionic gonadotrophin (HCG) secreted by the implanting blastocyst. This study investigated the expression of components of the synthetic pathway for progesterone in human corpora lutea in the presence and absence of HCG in vivo. Corpora lutea were obtained from: (i) normally cycling women at the time of hysterectomy and classified on the basis of the urinary luteinizing hormone (LH) surge as early (n = 3), mid- (n = 3), or late luteal (n = 3); or (ii) women who had received daily doubling doses of HCG (n = 3) to `rescue' the corpus luteum. Expression patterns of steroidogenic acute regulatory protein (StAR), cytochrome P450 cholesterol side-chain cleavage (P450scc) and 3ß-hydroxysteroid dehydrogenase (3ß-HSD) were investigated by Northern blotting, in-situ hybridization and immunohistochemistry. Luteal `rescue' with HCG was associated with the continued expression of these components. In the late luteal phase, in the absence of HCG, expression remained but was more variable. The expression of 3ß-HSD mRNA was significantly reduced during the luteal phase (P < 0.01). In conclusion, during luteal `rescue', HCG acts to maintain the steroidogenic pathway. In the absence of HCG, the decline in progesterone production begins in the presence of the main components of the steroidogenic pathway. While unlikely to initiate this decline, the altered expression levels of these components, particularly that of 3ß-HSD, may contribute to the continued reduction in progesterone production.
corpus luteum/enzymes/HCG/steroidogenesis/steroidogenic acute regulatory protein
2 Present address: Department of Obstetrics and Gynaecology, University of Sydney, Westmead Hospital, Westmead, Sydney, Australia
3 To whom correspondence should be addressed
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Y. Jarvela, A. Ruokonen, and A. Tekay Effect of rising hCG levels on the human corpus luteum during early pregnancy Hum. Reprod., August 10, 2008; (2008) den299v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Young, M. F. Menadue, and T. C. Lavranos Effects of the insecticide amitraz, an {alpha}2-adrenergic receptor agonist, on human luteinized granulosa cells Hum. Reprod., November 1, 2005; 20(11): 3018 - 3025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W C. Duncan, E. Gay, and J. A Maybin The effect of human chorionic gonadotrophin on the expression of progesterone receptors in human luteal cells in vivo and in vitro Reproduction, July 1, 2005; 130(1): 83 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family Endocr. Rev., June 1, 2005; 26(4): 525 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xu, R.L. Stouffer, R.P. Searles, and J.D. Hennebold Discovery of LH-regulated genes in the primate corpus luteum Mol. Hum. Reprod., March 1, 2005; 11(3): 151 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A Maybin and W C. Duncan The human corpus luteum: which cells have progesterone receptors? Reproduction, October 1, 2004; 128(4): 423 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Madhra, E. Gay, H. M. Fraser, and W.C. Duncan Alternative splicing of the human luteal LH receptor during luteolysis and maternal recognition of pregnancy Mol. Hum. Reprod., August 1, 2004; 10(8): 599 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kohen, O. Castro, A. Palomino, A. Munoz, L. K. Christenson, W. Sierralta, P. Carvallo, J. F. Strauss III, and L. Devoto The Steroidogenic Response and Corpus Luteum Expression of the Steroidogenic Acute Regulatory Protein after Human Chorionic Gonadotropin Administration at Different Times in the Human Luteal Phase J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3421 - 3430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wulff, S. E. Dickson, W. C. Duncan, and H. M. Fraser Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization Hum. Reprod., December 1, 2001; 16(12): 2515 - 2524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Devoto, P. Kohen, R. R. Gonzalez, O. Castro, I. Retamales, M. Vega, P. Carvallo, L. K. Christenson, and J. F. Strauss III Expression of Steroidogenic Acute Regulatory Protein in the Human Corpus Luteum throughout the Luteal Phase J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5633 - 5639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-J. Tai, S. K. Kang, C.-R. Tzeng, and P. C. K. Leung Adenosine Triphosphate Activates Mitogen-Activated Protein Kinase in Human Granulosa-Luteal Cells Endocrinology, April 1, 2001; 142(4): 1554 - 1560. [Abstract] [Full Text]
|
|
|
|
|
|
C.-J. Tai, S. K. Kang, K.-C. Choi, C.-R. Tzeng, and P. C. K. Leung Role of Mitogen-Activated Protein Kinase in Prostaglandin F2{{alpha}} Action in Human Granulosa-Luteal Cells J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 375 - 380. [Abstract] [Full Text]
|
|
|
|
|
|
C.L. Chaffin, G.A. Dissen, and R.L. Stouffer Hormonal regulation of steroidogenic enzyme expression in granulosa cells during the peri-ovulatory interval in monkeys Mol. Hum. Reprod., January 1, 2000; 6(1): 11 - 18. [Abstract] [Full Text] [PDF]
|
|